Psych-STRATA took part in two of Europe’s most influential events in brain and mental health research: the ECNP Congress 2025 in Amsterdam and the BID 2025 in Brussels.
Both events created valuable opportunities to share the project’s vision for personalised, data-driven, and patient-centred mental health care across Europe.
Advancing personalised psychiatry at the ECNP Congress 2025
The European College of Neuropsychopharmacology (ECNP) Congress 2025 is Europe’s largest meeting for applied neuroscience. It brings together thousands of researchers, clinicians, and innovators to exchange ideas and share the latest findings in neuroscience, pharmacology, and mental health.
At this year’s event, Psych-STRATA featured among the leading research initiatives shaping the future of psychiatry. The project focuses on early detection of treatment resistance and the development of stratified treatment algorithms for people living with major depression and bipolar disorder.
In addition, its work aligns with the ECNP theme of translational research and clinical innovation. By combining genetic, biological, clinical, and digital data, Psych-STRATA develops evidence-based tools that support treatment decisions and improve patient outcomes.
Connecting innovation and collaboration at Brain Innovation Days 2025
Following the ECNP Congress, Psych-STRATA joined the Brain Innovation Days 2025 in Brussels. This dynamic forum unites experts in brain research, digital health, policy, and industry. Moreover, it focuses on how collaboration can accelerate progress in brain and mental health through innovation and knowledge exchange.
Strengthening Europe’s leadership in mental health research
Participation in both events highlights Psych-STRATA’s active role in Europe’s mental health research landscape. Furthermore, by engaging with the wider scientific and innovation community, the project continues to build partnerships and promote collaboration that turns research into real-world results.
Psych-STRATA remains dedicated to creating a future where mental health care is predictive, personalised, and accessible. As a result, individuals affected by depression and bipolar disorder can benefit from the most advanced and effective treatments available.
